SP SOMASHEKHAR, RİCHA JAİSWAL, ROHİT KUMAR, BC ASHOK, SUSMİTA RAKSHİT, AMİT RAUTHAN, HK KARTHİK, ARCHA PRASAD, HERRA ISLAM, AARON FERNANDES, ELROY SALDAHANA, KR ASHWİN
European Journal of Breast Health - 2022;18(3):289-291
Mucormycosis is a rare, but potentially fatal, fungal infection which is caused by mucormyctes. These forms of fungi are typically known to infect immuno-compromised individuals but are rare in immunocompetent individuals. Herein, we report the case of a 52 year-old female who was diagnosed with right breast carcinoma in Manipal Hospital, a tertiary cancer care center. The patient was a known diabetic and hypertensive and who had recently recovered from coronavirus disease-2019 (COVID-19) pneumonia. In the due course of management, she developed mucormycosis infection at the operative site in her right breast where she had a radiation therapy-induced wound. This patient was successfully treated with an aggressive regimen of early surgical debridement along with administration of systemic amphotericin B.
